Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous Lymphoma (REV-LEG)
This study is currently recruiting participants.
Verified February 2013 by University Hospital, Bordeaux
Study NCT01556035
Information provided by University Hospital, Bordeaux
First Received on March 12, 2012.
Last Updated on February 20, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
